Department of Pharmacobiology, Center for Research and Advanced Studies (CINVESTAV), México City, Mexico.
Laboratory of Behavioral Pharmacology, Neuroscience Research Direction, National Institute of Psychiatry, México City, Mexico.
Neuroscience. 2014 Mar 7;261:11-22. doi: 10.1016/j.neuroscience.2013.12.035. Epub 2013 Dec 25.
Sex differences exist in the depressive disorder prevalence and response to treatment. Several studies suggest that females respond better than males to the action of selective serotonin reuptake inhibitors (SSRIs), suggesting that gonadal hormones modulate mood and the response to these drugs. Sexual steroid hormones exert organizational actions (perennial and on early development) and activational effects (transient and on differentiated tissues). The aim of this study was to analyze sex differences in the forced swim test (FST) in animals without treatment and after fluoxetine (FLX, 0, 2.5, 5.0 and 10.0mg/kg). Initially, we compared male and female adult rats under control conditions or after altering their sexual differentiation process (at day 5 postnatally, PN, 60μg of testosterone propionate to females and male castration to induce or preclude masculinization, respectively). To further analyze if the sex differences depend on organizational or activational steroid hormone action we tested the same animals before and after adult gonadectomy. To prevent variations depending upon the estrous cycle, control and masculinized females were tested in estrus. Control females showed lower immobility and required lower doses of FLX (5mg/kg), to show an antidepressant-like effect, than males (10mg/kg), even after adult gonadectomy. In control males adult orchidectomy prevented FLX's action. Neonatally masculinized females exhibited analogous levels of immobility than control ones; before ovariectomy they responded to FLX similar to controls, but after the surgery they did not respond to fluoxetine. Neonatally orchidectomized males exhibited similar immobility values and response to FLX than control females. The findings suggest that the sex difference in despair depends on the hormones organizational effects and, in males, the response to FLX relies on organizational and activational actions.
性别的差异存在于抑郁障碍的患病率和对治疗的反应中。有几项研究表明,女性对选择性 5-羟色胺再摄取抑制剂(SSRIs)的作用反应优于男性,这表明性腺激素调节情绪和对这些药物的反应。性甾体激素发挥组织作用(永久性和早期发育)和激活作用(瞬时和分化组织)。本研究旨在分析未治疗和氟西汀(FLX,0、2.5、5.0 和 10.0mg/kg)治疗后动物强迫游泳试验(FST)中的性别差异。最初,我们比较了在对照条件下或在改变其性分化过程后(在出生后第 5 天,PN,分别给雌性 60μg 丙酸睾酮和雄性去势以诱导或排除男性化)的成年雄性和雌性大鼠。为了进一步分析性别差异是否取决于组织或激活的类固醇激素作用,我们在成年性腺切除前后测试了相同的动物。为了防止因发情周期而产生变化,测试了对照和雄性化雌性动物的发情期。与雄性相比,对照雌性的不动性较低,需要较低剂量的 FLX(5mg/kg)才能表现出抗抑郁样作用,即使在成年性腺切除后也是如此。在对照雄性中,成年去势可防止 FLX 的作用。新生期雄性化雌性的不动性与对照雌性相似;在卵巢切除术前,它们对 FLX 的反应与对照组相似,但手术后它们对氟西汀没有反应。新生期去势雄性的不动性值和对 FLX 的反应与对照雌性相似。这些发现表明,绝望中的性别差异取决于激素的组织作用,而在雄性中,对 FLX 的反应依赖于组织和激活作用。